1. Expression pattern and prognostic value of circadian clock genes in pancreatic adenocarcinoma
- Author
-
Le-Le Zhang, Qi-Kuan He, Yu-Kai Xiang, Zhong-Jing Zhang, and Yan-Ning Lv
- Subjects
Physiology ,Circadian clock ,Value (computer science) ,030209 endocrinology & metabolism ,Adenocarcinoma ,Biology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Circadian Clocks ,Physiology (medical) ,Gene expression ,medicine ,Humans ,Circadian rhythm ,Nomogram ,Prognosis ,medicine.disease ,Circadian Rhythm ,Gene Expression Regulation, Neoplastic ,Pancreatic Neoplasms ,Cancer research ,Carcinogenesis ,030217 neurology & neurosurgery - Abstract
Accumulating studies indicate that circadian clock genes are pivotal regulators of tumorigenesis and development of various cancers. Nevertheless, their implications in pancreatic adenocarcinoma (PAAD) remain poorly characterized. We investigated the expression pattern of circadian clock genes and evaluated their prognostic values in PAAD. Firstly, we systematically analyzed data from The Cancer Genome Atlas (TCGA) database pertaining to patient clinical information and gene expression data. We found that 19 of 20 circadian clock genes showed significantly different expression levels in comparisons between PAAD and normal tissues. In addition, 10 circadian clock genes with regression coefficients were selected to construct a new risk signature, which was then identified as an independent prognostic factor for PAAD. Mechanistically, circadian clock genes in PAAD may impact the basic state of cells and the composition of tumor-infiltrating immune cells, thus affecting disease prognosis. Finally, we construct a novel prognostic nomogram on the basis of histological nodes and risk score to precisely predict prognosis of patients with PAAD. In conclusion, our study uncovered the important role of circadian clock genes in PAAD and developed a risk signature as a promising prognostic biomarker for patients with PAAD.
- Published
- 2021